Let down by the one you love – CQC chair calls for ‘serious change’

David Prior, CQC chairman, suggests “serious change” is necessary to ensure the survival of his 'beloved' NHS.

New A&E targets will avoid “beating hospitals with a stick”

NHS England are looking develop “more meaningful” A&E targets to avoid "beating hospitals with a stick" and ease pressure on Trusts.

NHS would “struggle” without foreign workers

Statistics on foreign workers suggest NHS services would “struggle” without immigrants.

“Whole-stay doctor” for patients in hospital

Health secretary Jeremy Hunt has called for a greater ‘continuity of care’ in hospitals, with all patients having a “whole-stay doctor”.

Environment-tailored healthcare could save money

NHS England guidance has identified 20 interventions, tailored to commissioners’ environments, that could boost local health care services and ease the funding deficit.

New mental health strategy to tackle “unacceptable” standards

Deputy prime minister Nick Clegg unveils a new mental health strategy to tackle “unacceptable” standards.

NHS England champions the role of the pharmacy in new campaign

NHS England is targeting “unnecessary” hospital admissions with a new campaign that urges the public to seek treatment early and highlights the role of the pharmacist in minor care.

External reviews for Foundation Trusts to tackle rise in governance problems

Healthcare watchdog Monitor has called for ‘robust’ external reviews on Foundation Trusts every three years to tackle the rise in governance problems.

60% rise in cost of A&E temps

Data shows a 60% increase in NHS spending on temporary doctors to cover shortages in A&E over the past three years.

NICE may only approve treatments that offer “wider societal benefits”

Concerns have been raised that new NICE criteria that offers funding based on “wider societal benefits” could see the elderly missing out.

Latest articles

Image of two heads conversing through text bubbles with light bulbs, question marks and cogs to show QBiotics and MSD collaborate on unresectable melanoma

QBiotics and MSD collaborate on unresectable melanoma

QBiotics Group Limited, a life sciences company developing novel anticancer and wound healing pharmaceuticals, has entered into an agreement with MSD to evaluate use...
Image of a healthcare professional in PPE washing their hands to show Impact of long-term COVID-19 symptoms on patients and doctors

Long-term COVID-19 symptoms in patients and doctors

Data released today as part of the BMA’s latest survey of doctors during the pandemic reveals significant levels of long-term COVID-19 symptoms in patients...
Image of a magnifying glass held over covid virus to show 'One Million' study to monitor safety and effectiveness of COVID-19 vaccines

‘One Million’ study to monitor COVID-19 vaccine safety and effectiveness

A UK consortium has announced plans for a 'One Million' Post-Authorisation Study to monitor the safety and effectiveness of the COVID-19 vaccine in real-life...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a magnifying glass held over covid virus to show 'One Million' study to monitor safety and effectiveness of COVID-19 vaccines

‘One Million’ study to monitor COVID-19 vaccine safety and effectiveness

A UK consortium has announced plans for a 'One Million' Post-Authorisation Study to monitor the safety and effectiveness of the COVID-19 vaccine in real-life...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Woman holding swab: COVID-19 pandemic

COVID-19: Pharma on the frontline

Pharma stepped up to support the NHS, the country and the World during the COVID-19 pandemic. Pf brings you some examples of pharma on...
Image of man and woman shaking hands in front of a contract to show Advent Life Sciences announces sale of KaNDy Therapeutics to Bayer AG

Advent Life Sciences announces sale of KaNDy Therapeutics to Bayer AG

Advent Life Sciences, a leading European life sciences venture capital firm, has announced the sale of its portfolio company, KaNDy Therapeutics Ltd, to Bayer...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription